AXS-14 (esreboxetine) is a highly selective and potent norepinephrine reuptake inhibitor being developed for the management of fibromyalgia. Esreboxetine is the SS-enantiomer of racemic reboxetine.
The press release promoting the study asserts that “universal SEL programs are a sound investment in education systems ...
Listen and subscribe to Morningstar’s The Long View from your mobile device: Apple Podcasts | Spotify Our guest on the ...
Opinion
23hOpinion
Could ChatGPT convince you to buy something? Threat of manipulation looms as AI companies gear up to sell ads
The functionality of ChatGPT Search and its Atlas browser is not really new. Meta, commercial AI competitor Perplexity and even ChatGPT itself have had similar AI search features for years, and both ...
John Holmes and colleagues argue for a precautionary approach that is guided by public health interests and considers both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback